These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22292457)

  • 1. Type of desmin expression in cardiomyocytes - a good marker of heart failure development in idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Kulawik T; Pronicki M; Karkucińska-Więckowska A; Szymańska-Dębińska T; Gil K; Lagwinski N; Czarnowska E
    J Intern Med; 2012 Sep; 272(3):287-97. PubMed ID: 22292457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of low desmin expression in cardiomyocytes in patients with idiopathic dilated cardiomyopathy.
    Pawlak A; Gil RJ; Grajkowska W; Nasierowska-Guttmejer AM; Rzezak J; Kulawik T
    Am J Cardiol; 2013 Feb; 111(3):393-9. PubMed ID: 23178054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure.
    Pawlak A; Gil RJ; Kasprzak J; Walczak E; Słysz A
    Kardiol Pol; 2009 Jul; 67(7):724-33. PubMed ID: 19649994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.
    Hasegawa K; Fujiwara H; Doyama K; Mukoyama M; Nakao K; Fujiwara T; Imura H; Kawai C
    Am J Pathol; 1993 Jan; 142(1):107-16. PubMed ID: 8424448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of desmin activity using immunohistochemical and immunofluorescent staining of myocardial biopsies in patients with chronic heart failure. Comparison of the two methods.
    Pawlak A; Gil RJ; Walczak E; Fidziańska A
    Kardiol Pol; 2007 Mar; 65(3):229-35; discussion 236. PubMed ID: 17436150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proposed new classification of coronary microcirculation as the predictor of the heart failure progression in idiopathic dilated cardiomyopathy.
    Gil KE; Pawlak A; Frontczak-Baniewicz M; Gil RJ; Nasierowska-Guttmejer A
    Cardiovasc Pathol; 2015; 24(6):351-8. PubMed ID: 26382083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
    Psarras S; Mavroidis M; Sanoudou D; Davos CH; Xanthou G; Varela AE; Panoutsakopoulou V; Capetanaki Y
    Eur Heart J; 2012 Aug; 33(15):1954-63. PubMed ID: 21525025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in desmin expression in patients with cardiac diastolic dysfunction and preserved or reduced ejection fraction.
    Pawlak A; Gil RJ; Nasierowska-Guttmejer AM; Kasprzak JD
    Adv Med Sci; 2015 Mar; 60(1):148-55. PubMed ID: 25732530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.
    Di Somma S; Di Benedetto MP; Salvatore G; Agozzino L; Ferranti F; Esposito S; La Dogana P; Scarano MI; Caputo G; Cotrufo M; Santo LD; de Divitiis O
    Eur J Heart Fail; 2004 Jun; 6(4):389-98. PubMed ID: 15182762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of desmin expression in idiopathic dilated cardiomyopathy are related to the desmin mRNA and ubiquitin expression.
    Pawlak A; Rejmak-Kozicka E; Gil KE; Ziemba A; Kaczmarek L; Gil RJ
    J Investig Med; 2019 Jan; 67(1):11-19. PubMed ID: 30097466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy.
    Karaahmet T; Tigen K; Dundar C; Pala S; Guler A; Kilicgedik A; Cevik C; Mahmutyazicioglu K; Isiklar I; Basaran Y
    Echocardiography; 2010 Sep; 27(8):954-60. PubMed ID: 20849483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmin expression in human cardiomyocytes and selected clinical and echocardiographic parameters in patients with chronic heart failure.
    Pawlak A; Gil RJ; Walczak E; Seweryniak P
    Kardiol Pol; 2009 Sep; 67(9):955-61. PubMed ID: 19838951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
    Limongelli G; Pacileo G; Ancona R; Eusebio G; D'Andrea A; Romano M; Di Salvo G; Rea A; Calabró P; Romano G; Maiello C; Calabró R
    Am J Cardiol; 2010 Mar; 105(5):716-20. PubMed ID: 20185022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-related factors p53, bcl-2 and the defects of force transmission in dilated cardiomyopathy.
    Tsipis A; Athanassiadou AM; Athanassiadou P; Kavantzas N; Agrogiannis G; Patsouris E
    Pathol Res Pract; 2010 Sep; 206(9):625-30. PubMed ID: 20591580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: a study based on right ventricular endomyocardial biopsies.
    Benvenuti LA; Freitas HF; Mansur AJ; Higuchi ML
    Int J Cardiol; 2007 Mar; 116(2):279-80. PubMed ID: 16839625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.